Barka, Oman – By the end of 2024, Khazaen Economic City in South Al Batinah Governorate successfully localized nine major health sector projects, attracting both local and international investors. The total investment for these projects reached OMR 156 million ($405 million), marking a significant milestone in Oman’s healthcare and pharmaceutical industries.
Transforming Oman’s Healthcare Sector
Khazaen Economic City has positioned itself as a premier hub for pharmaceutical and medical investments, fostering projects that enhance healthcare infrastructure and drive economic diversification. The latest investments focus on:
- Human vaccine production to support regional and global immunization efforts
- Pharmaceutical manufacturing, including essential medicines and medical supplies
- Advanced medical storage and import facilities to strengthen Oman’s healthcare supply chain
A Strategic Hub for Medical Innovation
As part of Oman Vision 2040, Khazaen Economic City is emerging as a strategic destination for medical and biotech investments. The integrated zone provides state-of-the-art infrastructure, tax incentives, and streamlined business operations, attracting global pharmaceutical giants and regional healthcare providers.
Boosting Economic Growth & Healthcare Excellence
With the OMR 156 million investment, Oman aims to:
- Enhance self-sufficiency in pharmaceutical production
- Reduce dependence on medical imports
- Strengthen the nation’s position as a regional healthcare hub
Future Prospects
The localization of these projects is expected to create job opportunities, promote innovation, and drive Oman’s healthcare transformation. With continued investment in biotechnology, medical research, and digital health solutions, Khazaen Economic City is set to become a leading medical and pharmaceutical hub in the Middle East.
